arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1302.0503q-bio.QM
收藏

ART是否会增加TB的群体水平发生率?

Could ART increase the population level incidence of TB?

Brian Gerard Williams

摘要:

艾滋病毒增加了一个人患结核病的可能性。开始抗逆转录病毒治疗(ART)可以降低他们患结核病的风险,但不能达到艾滋病毒阴性人群的水平。由于接受抗逆转录病毒治疗的艾滋病毒阳性者可以预期在几十年内过上正常生活,这就增加了他们感染的风险增加的可能性,这种风险持续很长一段时间,可能导致结核病的人口发病率增加。在这里,我们调查了可能发生这种情况的条件,并表明如果HIV阳性患者在其CD 4+细胞计数大于350/μ L时开始ART,并且覆盖率很高,ART不会导致HIV的长期增加。只有当人们很晚开始抗逆转录病毒治疗,并且抗逆转录病毒治疗的覆盖率很低时,开始接受抗逆转录病毒治疗的人才可能增加结核病的人口发病率。

英文摘要:

HIV increases the likelihood that a person will develop TB. Starting them on anti-retroviral therapy (ART) reduces their risk of TB but not to the level in HIV negative people. Since HIV-positive people who are on ART can expect to live a normal life for several decades this raises the possibility that their elevated risk of infection, lasting for a long time, could lead to an increase in the population level incidence of TB. Here we investigate the conditions under which this could happen and show that provided HIV-positive people start ART when their CD4+ cell count is greater than 350/microL and that there is high coverage, ART will not lead to a long-term increase in HIV. Only if people start ART very late and there is low coverage of ART might starting people on ART increase the population level incidence of TB.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑